{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:24:56Z","timestamp":1787286296343,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Invasive fusariosis is a rare but severe fungal infection associated with high morbidity and mortality in immunocompromised children, and pediatric\u2011specific standardized management strategies remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a 10\u2011year multicenter retrospective cohort study across 28 pediatric hematology centers of the French Society for the Fight Against Cancer and Leukemia in Children and Adolescents, combined with a structured literature review conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 statement. Children \u226418 years with proven or probable invasive fusariosis between 2012 and 2022 were included. Primary outcomes were infection response and mortality; secondary outcomes included dissemination patterns and impact on hematologic treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 55 children were included (19 from the French cohort and 36 from the literature). The median age was 9 years, and 87% had underlying hematologic malignancies. Disseminated fusariosis occurred in 73% of patients. Skin involvement was the most frequent manifestation (82%). Voriconazole (91%) and liposomal amphotericin B (64%) were the most used antifungals; 75% of patients received combination therapy. Infection control at the end of antifungal therapy was achieved in 67% of patients. Overall mortality was 55%, with fusariosis contributing directly or indirectly to 45% of deaths. Disseminated disease was associated with a higher risk of fusariosis\u2011related mortality (odds ratio 4.7, 95% confidence interval [1.1\u201319.2],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Invasive fusariosis remains a highly lethal infection in immunocompromised children, particularly in disseminated forms, and significantly interferes with oncologic treatment. Early diagnosis and aggressive antifungal treatment, combined with continued management of the underlying condition, are critical to improving outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005375","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:01:18Z","timestamp":1787284878000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Invasive Fusarium Infections in Immunocompromised Children"],"prefix":"10.1097","author":[{"given":"Aziz","family":"Abgaou","sequence":"first","affiliation":[{"name":"Pediatric Hematology-Oncology Unit, Montpellier University Hospital, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Sirvent","sequence":"additional","affiliation":[{"name":"Pediatric Hematology-Oncology Unit, Montpellier University Hospital, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Brethon","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Immunology Department, Ho\u0302pital Robert Debre\u0301, GHU AP-HP Nord Universit\u00e9 Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Jubert","sequence":"additional","affiliation":[{"name":"Pediatric Hematology-Oncology Unit, CHU Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Cances","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Unit, CHU Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Bohrer","sequence":"additional","affiliation":[{"name":"Pediatric Hematology-Oncology Unit, CHU de La R\u00e9union H\u00f4pital F\u00e9lix Guyon, Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Dominique","family":"Tabone","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, A. Trousseau Hospital, Sorbonne Universit\u00e9, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Sterin","sequence":"additional","affiliation":[{"name":"Pediatric Hematology-Oncology Unit, CHU Marseille, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Domenech","sequence":"additional","affiliation":[{"name":"Institute of Pediatric Hematology and Oncology, University Lyon 1, Hospices Civils de Lyon, Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8793-4903","authenticated-orcid":false,"given":"Alexandre","family":"Theron","sequence":"additional","affiliation":[{"name":"Pediatric Hematology-Oncology Unit, Montpellier University Hospital, University of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"R1-20260821","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpeds.2021.05.016","article-title":"Invasive fungal infections in immunocompromised children: novel insight following a national study.","volume":"236","author":"Olivier-Gougenheim","year":"2021","journal-title":"J Pediatr"},{"key":"R2-20260821","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/1469-0691.12409","article-title":"Improvement in the outcome of invasive fusariosis in the last decade.","volume":"20","author":"Nucci","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"R3-20260821","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12281-024-00497-1","article-title":"Fusariosis in children.","volume":"18","author":"Carlesse","year":"2024","journal-title":"Curr Fungal Infect Rep"},{"key":"R4-20260821","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jpids\/pit080","article-title":"Invasive fusariosis: a single pediatric center 15-year experience.","volume":"4","author":"Schwartz","year":"2015","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R5-20260821","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R6-20260821","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/INF.0b013e318257f646","article-title":"A knee ulcer in a teenager with acute myeloid leukemia.","volume":"31","author":"Zegarra-Linares","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20260821","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cmi.2014.09.004","article-title":"An outbreak of invasive fusariosis in a children\u2019s cancer hospital.","volume":"21","author":"Litvinov","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"R8-20260821","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/1346-8138.15168","article-title":"Cutaneous fusariosis caused by Fusarium lichenicola in a child with hyper-immunoglobulin E syndrome.","volume":"47","author":"Shi","year":"2020","journal-title":"J Dermatol"},{"key":"R9-20260821","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/pde.15179","article-title":"Disseminated bisifusarium infection following toxic epidermal necrolysis in a child with B-cell acute lymphoblastic leukemia.","volume":"40","author":"Brent","year":"2023","journal-title":"Pediatr Dermatol"},{"key":"R10-20260821","first-page":"39","article-title":"Disseminated fusariosis in children: report of two cases in girls with leukemia.","volume":"8","author":"De la Espriella","year":"2022","journal-title":"Curr Med Mycol"},{"key":"R11-20260821","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/1120009X.2020.1867946","article-title":"Disseminated fusariosis in immunocompromised children: a case series and review of literature.","volume":"33","author":"Riojas Hern\u00e1ndez","year":"2021","journal-title":"J Chemother"},{"key":"R12-20260821","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.12998\/wjcc.v9.i21.6049","article-title":"Disseminated Fusarium bloodstream infection in a child with acute myeloid leukemia: a case report.","volume":"9","author":"Ning","year":"2021","journal-title":"World J Clin Cases"},{"key":"R13-20260821","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijid.2022.11.019","article-title":"Fusarium and Lomentospora coinfection in a pediatric patient with acute myelogenous leukemia: always Occam\u2019s razor may not apply.","volume":"126","author":"Mah","year":"2023","journal-title":"Int J Infect Dis"},{"key":"R14-20260821","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw183","article-title":"Fusarium osteomyelitis in a patient with pearson syndrome: case report and review of the literature.","volume":"3","author":"Hiebert","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"R15-20260821","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1684\/ejd.2022.4319","article-title":"Successful treatment of disseminated amphotericin-resistant fusariosis in a paediatric patient with acute lymphoblastic leukaemia: a case report and literature review.","volume":"32","author":"Zhong","year":"2022","journal-title":"Eur J Dermatol"},{"key":"R16-20260821","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s11046-018-0257-6","article-title":"Infections caused by Fusarium species in pediatric cancer patients and review of published literature.","volume":"183","author":"Arnoni","year":"2018","journal-title":"Mycopathologia"},{"key":"R17-20260821","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/INF.0000000000001396","article-title":"Disseminated fusariosis in immunocompromised children\u2014analysis of recent cases identified in the global fungiscope registry.","volume":"36","author":"Hassler","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R18-20260821","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13756-017-0247-3","article-title":"Outbreak of Fusarium oxysporum infections in children with cancer: an experience with 7 episodes of catheter-related fungemia.","volume":"6","author":"Carlesse","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"issue":"Suppl 1","key":"R19-20260821","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0163-4453(94)95911-0","article-title":"Clinical patterns of Fusarium infections in immunocompromised patients.","volume":"28","author":"Martino","year":"1994","journal-title":"J Infect"},{"key":"R20-20260821","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/clinids\/13.6.1077","article-title":"Disseminated infection with Fusarium in recipients of bone marrow transplants.","volume":"13","author":"Gamis","year":"1991","journal-title":"Rev Infect Dis"},{"key":"R21-20260821","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/jof8040387","article-title":"Invasive fusariosis in pediatric hematology\/oncology and stem cell transplant patients: a report from the Israeli Society of Pediatric Hematology-Oncology.","volume":"8","author":"Benish","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"R22-20260821","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00014-07","article-title":"Fusarium infections in immunocompromised patients.","volume":"20","author":"Nucci","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"R23-20260821","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1128\/JCM.00942-07","article-title":"DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients.","volume":"45","author":"Spiess","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R24-20260821","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1128\/JCM.37.8.2434-2438.1999","article-title":"Specific detection of fusarium species in blood and tissues by a PCR technique.","volume":"37","author":"Hue","year":"1999","journal-title":"J Clin Microbiol"},{"key":"R25-20260821","first-page":"1165","article-title":"Update on the treatment of disseminated fusariosis: focus on voriconazole.","volume":"3","author":"Stanzani","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"R26-20260821","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1086\/374557","article-title":"Voriconazole treatment for less-common, emerging, or refractory fungal infections.","volume":"36","author":"Perfect","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R27-20260821","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/S1470-2045(20)30723-3","article-title":"8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation.","volume":"22","author":"Groll","year":"2021","journal-title":"Lancet Oncol"},{"key":"R28-20260821","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","article-title":"Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology.","volume":"21","author":"Hoenigl","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"R29-20260821","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1128\/JCM.00318-16","article-title":"Role of antifungal susceptibility testing in non-aspergillus invasive mold infections.","volume":"54","author":"Lamoth","year":"2016","journal-title":"J Clin Microbiol"},{"key":"R30-20260821","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/cid\/ciad309","article-title":"Fosmanogepix therapy of disseminated fusarium infection.","volume":"77","author":"Winston","year":"2023","journal-title":"Clin Infect Dis"},{"key":"R31-20260821","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1186\/s12879-024-10143-3","article-title":"Review of the novel antifungal drug olorofim (F901318).","volume":"24","author":"Vanbiervliet","year":"2024","journal-title":"BMC Infect Dis"},{"key":"R32-20260821","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/QCO.0000000000000776","article-title":"How different is invasive fusariosis in pediatric patients than in adults? A systematic review.","volume":"34","author":"Rossato","year":"2021","journal-title":"Curr Opin Infect Dis"},{"key":"R33-20260821","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1439-0507.2011.02158.x","article-title":"Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.","volume":"55","author":"Moriyama","year":"2012","journal-title":"Mycoses"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:01:22Z","timestamp":1787284882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005375"}},"subtitle":["A 10-year Multicenter Retrospective Study and Literature Review"],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":33,"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005375","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}